首页> 外文OA文献 >Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.

【2h】

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.

机译：大麻素1受体阻滞剂利莫那班对超重患者体重减轻和心血管危险因素的影响：RIO-Europe研究的1年经验。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Van Gaal, Luc F; Rissanen, Aila M; Scheen, André; Ziegler, Olivier; Rossner, Stephan;
展开▼
作者单位

展开▼
年度 2005
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. [J] . Van Gaal LF, Rissanen AM, Scheen AJ, The Lancet . 2005,第9468期

机译：大麻素1受体阻滞剂利莫那班对超重患者体重减轻和心血管危险因素的影响：RIO-Europe研究的1年经验。
2. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. [J] . Pi Sunyer FX, Aronne LJ, Heshmati HM, JAMA: the Journal of the American Medical Association . 2006,第7期

机译：利莫那班（一种大麻素1受体阻滞剂）对超重或肥胖患者体重和心血管代谢危险因素的影响：RIO-北美：一项随机对照试验。
3. A low carbohydrate Mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: a 1-year prospective randomized intervention study. [J] . Elhayany A, Lustman A, Abel Diabetes, obesity & metabolism . 2010,第3期

机译：低碳水化合物的地中海饮食可改善超重2型糖尿病患者的心血管危险因素和糖尿病控制：一项为期1年的前瞻性随机干预研究。
4. Overweight and cardiovascular pathology risk factors in Moscow school age students [C] . Gazina D.N., Gurevich K.G. International Society for Heart Research . 2011

机译：莫斯科学年学生的超重和心血管病理学风险因素
5. A Comparison of Biological, Physical, and Psychological Risk Factors for Cardiovascular Disease In Overweight/Obese Individuals With and Without Prediabetes [D] . Liu, Tingting 2015

机译：超重/肥胖个体中有和没有前驱糖尿病的心血管疾病的生物学，生理和心理风险因素的比较
6. Effects of the Cannabinoid-1 Receptor Antagonist/Inverse Agonist Rimonabant on Satiety Signaling in Overweight People with Schizophrenia [O] . Kimberly R. Warren, Robert W. Buchanan, Stephanie Feldman, -1

机译：在超重人群精神分裂症大麻素1受体拮抗剂/反向激动剂利莫那班对饱足感信号传导
7. Effects of the Cannabinoid-1 Receptor Blocker Rimonabant on Weight Reduction and Cardiovascular Risk Factors in Overweight Patients: 1-Year Experience From the RIO-Europe Study [O] . L.F. Van Gaal, A.M. Rissanen, A.J. Scheen, 2005

机译：大麻素-1受体阻滞剂乙二醇对超重患者减肥和心血管危险因素的影响：里约欧洲研究的1年经验

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.

著录项

引文网络

相似文献

相关主题

期刊订阅